Percutaneous coronary intervention adjunct for thrombosis prevention

Percutaneous coronary intervention adjunct for thrombosis prevention describes a therapeutic indication aimed at preventing acute, subacute, and late thrombotic complications in patients undergoing coronary revascularization

Percutaneous coronary intervention adjunct for thrombosis prevention describes a therapeutic indication aimed at preventing acute, subacute, and late thrombotic complications in patients undergoing coronary revascularization Adjunctive antithrombotic regimens address this risk by suppressing platelet aggregation and the coagulation cascade during and following the procedure, thereby maintaining coronary vessel patency and reducing ischemic cardiovascular events

Mechanical disruption of atherosclerotic plaques, vascular endothelial denudation, and the introduction of endovascular hardware—such as balloon catheters and intracoronary stents—stimulate platelet activation, adhesion, and cascade thrombin generation within the coronary arterial vasculature

Mechanical disruption of atherosclerotic plaques, vascular endothelial denudation, and the introduction of endovascular hardware—such as balloon catheters and intracoronary stents—stimulate platelet activation, adhesion, and cascade thrombin generation within the coronary arterial vasculature Without pharmacological inhibition, this prothrombotic state can lead to abrupt periprocedural vessel closure, stent thrombosis, distal microvascular embolization, and recurrent myocardial infarction Adjunc...

Without pharmacological inhibition, this prothrombotic state can lead to abrupt periprocedural vessel closure, stent thrombosis, distal microvascular embolization, and recurrent myocardial infarction